In Jun, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 24.890 volatility is expected. The weighted average target price per fuboTV share in Jun 2025 is: 3.44. the company was founded in 1987 and is headquartered in Gaithersburg, Maryland. Target values for the price of one fuboTV share for Jun 2025. In addition, the company is developing a COVID-19 vaccine against the pneumonia-like coronavirus, which is in the preclinical stage. In addition, it is developing candidate nanoparticle vaccines for clinical trials against the Ebola virus, which is in clinical trials stage I and a combined respiratory vaccine to protect against influenza and RSV. The company is also developing the RSV F vaccine for the elderly (60 years and older), which is in phase II clinical trials, as well as for healthy children aged six months to five years, who are in phase I clinical trials. Its leading adjuvant is Matrix-M, which is used to enable the vaccine to enhance the amplitude of the immune response and qualitatively change it, and to allow the immune system to attack microorganisms, and also to allow immunization with much smaller doses of antigen. The company’s leading vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate, which is in stage III clinical trials to protect infants from RSV disease through maternal immunization and NanoFlu, which is in phase III clinical trials for the treatment of seasonal influenza in the elderly. Month, Average, Low, High, Change from todays price. Together with its subsidiary Novavax AB, a late-stage biotechnology company, it discovers, develops and commercializes vaccines to prevent serious infectious diseases. Vaxart: 25,752 implied sales growth by 2025 A clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small. The average COWI price prediction of 2025 represents a +NaN increase from the last price of 0.00.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |